Fig. 2From: SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival?Participants timeline. Timeline depending on study arm and follow-up scheduleBack to article page